A growing business

Grifols is a global healthcare company that since 1909 has enhanced the health and well-being of people around the world.

A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries.

Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in both plasma and other biopharmaceuticals to enhance quality of life.

Grifols is focused on treating conditions across a broad range of therapeutic areas: neurology, immunology, hepatology and intensive care, pulmonology, hematology and infectious diseases.

A pioneer in the plasma industry, we have the largest network of donation centers in the world, with more than 390 centers across North America, Europe, Africa and the Middle East, and China through a partnership with Shanghai RAAS.

We are committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry.








R&D+I investment in the last 5 years

Grifols' global presence

Grifols, a growing global company, has a presence in more than 30 countries and regions and provides its innovative healthcare products and solutions in more than 110. Our long-term vision enables us to expand into new markets to further our mission of improving people’s health and well-being around the world.

Learn more about us


Our commitment to sustainability

Grifols' longstanding commitment to people and the planet entails helping society on all fronts by strengthening our positive social, economic and environmental impacts.

Read more